Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program...